5-aminolaevulinic acid (5-ALA) accumulates in GIST-T1 cells and photodynamic diagnosis using 5-ALA identifies gastrointestinal stromal tumors (GISTs) in xenograft tumor models

PLoS One. 2021 Apr 7;16(4):e0249650. doi: 10.1371/journal.pone.0249650. eCollection 2021.

Abstract

Gastrointestinal stromal tumor (GIST) diagnosis using conventional gastrointestinal endoscopy is difficult because such malignancies cannot be distinguished from other types of submucosal tumors. Photodynamic diagnosis (PDD) is based on the preferential uptake of photosensitizers by tumor tissues and its detection by fluorescence emission upon laser excitation. In this study, we investigated whether PDD using 5-aminolevulinic acid (5-ALA), a standard photosensitizer used worldwide, could be used for GIST diagnosis. 5-ALA is metabolized to endogenous fluorescent protoporphyrin IX (PpIX). We examined the accumulation of PpIX in GIST-T1 cells using flow cytometry and immunofluorescent staining. Furthermore, we established GIST-T1 xenograft mouse models and examined PpIX accumulation in the resultant tumors. PpIX accumulated in GIST-T1 cells and was localized mainly to lysosomes. PpIX accumulation was also observed in murine xenograft tumors. Moreover, tumor and normal tissues could be distinctly identified by relative PpIX fluorescence. Thus, our results demonstrated that PDD with 5-ALA has substantial clinical potential for GIST diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid
  • Animals
  • Cell Line, Tumor
  • Disease Models, Animal
  • Female
  • Flow Cytometry / methods
  • Fluorescence
  • Gastrointestinal Stromal Tumors / diagnosis*
  • Gastrointestinal Stromal Tumors / metabolism*
  • Humans
  • Levulinic Acids / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Photochemotherapy / methods
  • Photosensitizing Agents / metabolism
  • Protoporphyrins / metabolism
  • Xenograft Model Antitumor Assays / methods

Substances

  • Levulinic Acids
  • Photosensitizing Agents
  • Protoporphyrins
  • protoporphyrin IX

Grants and funding

This work was partially supported by JSPS KAKENHI (2017-2019) (grant number 18K08013) (to M. Tanaka); JSPS KAKENHI (2020-2022) (grant number 20K08361) (to M. Tanaka); Takeda Science Foundation (2018-2019) (to M. Tanaka); Kobayashi International Scholarship Foundation (2019) (to M. Tanaka); The Nitto Foundation (2019) (to M. Tanaka); The Murata Science Foundation (2019-2020) (to M. Tanaka); Research Foundation for Opto Science and Technology (2020) (to M. Tanaka); JSPS KAKENHI (2020-2021) grant number 20K16965 (to H. Ichikawa); JSPS KAKENHI (2020-2021) (grant number 20K16997) (to T. Suzuki); JSPS KAKENHI (2018-2020) (grant number 18K15758) (to H. Nishie); JSPS KAKENHI (2020-2022) (grant number 20K083919) (to H. Kataoka). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.